XRAY in the 13F filings
Dentsply Sirona Inc · CUSIP 24906P109
- Quarter end
- 30 Jun 2026
- the date the book describes
- Filed
- 27 Oct 2026
- latest of these filings; the earliest 3 Aug 2026
- Managers listing it
- 25
- at least, of 95 tracked, among listed positions
- Comparable managers
- 91
- filed both Q1 2026 and Q2 2026; 6 listed it in both
- Shares listed
- 28,243,953
- combined, among listed positions
- Reported value
- $299m
- combined, at the quarter end
AllianceBernstein LP. Values in this filing are at the previous quarter end's prices; its share count is the quarter end's.
Among the 91 comparable managers: 10 buyers (opened or added shares) and 19 sellers (trimmed or exited), at least, among listed positions. Their net change in shares was -12,993,587.
Managers listing XRAY in Q2 2026
25 of 25 holders
Largest increases and reductions, by shares
Increases
- AQR Capital Management LLCexisting position · 10,458,771 shares now+6,493,548
- Neuberger Berman Group LLCexisting position · 2,937,567 shares now+1,036,855
- Fidelity (FMR LLC)existing position · 1,568,128 shares now+964,788
- D. E. Shaw & Co.existing position · 2,987,178 shares now+554,459
- Bridgewater Associates LPnew position · 369,968 shares now+369,968
Reductions
- First Eagle Investment Management LLCexisting position · 851,347 shares now-14,276,586
- Renaissance Technologies LLCexisting position · 33,458 shares now-1,535,900
- Jane Street Group LLCexisting position · 39,913 shares now-970,949
- Marshall Wace LLPexisting position · 3,800,116 shares now-708,286
- Citadel Advisors LLCexisting position · 762,317 shares now-631,146
New positions and exits
New (1)
Exited (5)
- Freestone Grove Partners LPwas $27m
- Woodline Partners LPwas $8.1m
- Arrowstreet Capital LPwas $3.9m
- Man Group PLCwas $1.7m
- Schonfeld Strategic Advisors LLCwas $627k
Ownership over time
Tracked managers listing it, at least.
| Quarter | Holders | Reported value | Buyers | Sellers |
|---|---|---|---|---|
| Q1 2016 | 17 | $3.1bn | n.a. | n.a. |
| Q2 2016 | 18 | $3.0bn | n.a. | n.a. |
| Q3 2016 | 15 | $2.8bn | n.a. | n.a. |
| Q4 2016 | 14 | $2.7bn | n.a. | n.a. |
| Q1 2017 | 19 | $2.7bn | n.a. | n.a. |
| Q2 2017 | 13 | $2.6bn | n.a. | n.a. |
| Q3 2017 | 13 | $2.6bn | n.a. | n.a. |
| Q4 2017 | 12 | $2.6bn | n.a. | n.a. |
| Q1 2018 | 17 | $1.4bn | n.a. | n.a. |
| Q2 2018 | 12 | $933m | n.a. | n.a. |
| Q3 2018 | 18 | $1.6bn | n.a. | n.a. |
| Q4 2018 | 13 | $1.6bn | n.a. | n.a. |
| Q1 2019 | 13 | $1.8bn | n.a. | n.a. |
| Q2 2019 | 14 | $2.1bn | n.a. | n.a. |
| Q3 2019 | 16 | $1.9bn | n.a. | n.a. |
| Q4 2019 | 16 | $2.0bn | n.a. | n.a. |
| Q1 2020 | 16 | $1.5bn | n.a. | n.a. |
| Q2 2020 | 16 | $2.1bn | n.a. | n.a. |
| Q3 2020 | 14 | $2.3bn | n.a. | n.a. |
| Q4 2020 | 11 | $2.7bn | n.a. | n.a. |
| Q1 2021 | 16 | $3.7bn | n.a. | n.a. |
| Q2 2021 | 23 | $3.8bn | n.a. | n.a. |
| Q3 2021 | 18 | $3.3bn | n.a. | n.a. |
| Q4 2021 | 13 | $2.8bn | n.a. | n.a. |
| Q1 2022 | 16 | $2.8bn | n.a. | n.a. |
| Q2 2022 | 18 | $2.0bn | n.a. | n.a. |
| Q3 2022 | 17 | $1.5bn | n.a. | n.a. |
| Q4 2022 | 14 | $1.6bn | n.a. | n.a. |
| Q1 2023 | 11 | $2.2bn | n.a. | n.a. |
| Q2 2023 | 10 | $1.9bn | n.a. | n.a. |
| Q3 2023 | 15 | $1.7bn | n.a. | n.a. |
| Q4 2023 | 13 | $1.7bn | 9 | 7 |
| Q1 2024 | 12 | $1.1bn | 8 | 5 |
| Q2 2024 | 9 | $781m | 7 | 3 |
| Q3 2024 | 8 | $941m | 6 | 2 |
| Q4 2024 | 9 | $648m | 8 | 2 |
| Q1 2025 | 9 | $586m | 8 | 2 |
| Q2 2025 | 8 | $639m | 3 | 6 |
| Q3 2025 | 6 | $369m | 4 | 2 |
| Q4 2025 | 5 | $199m | 23 | 9 |
| Q1 2026 | 7 | $273m | 17 | 17 |
| Q2 2026 | 5 | $61m | 10 | 19 |
Compare with…
Holders over time, buyers and sellers, and the managers holding both, side by side for up to four stocks.
XRAY and LLY →XRAY and JNJ →XRAY and VRTX →Choose a stock to compare with XRAY →
How much of the picture this is
A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. It shows no shorts, cash, bonds or performance, and it is never today’s portfolio. Large books are listed to their largest positions, so a manager missing from this table may still hold a small position below that line. These are 95 tracked managers, not the institutional market.
Which funds own XRAY, latest filings →Back to the 13F Explorer →